Considerations for Management of Clinical Trials and Regulatory Filing Strategy in Light of COVID-19

Описание к видео Considerations for Management of Clinical Trials and Regulatory Filing Strategy in Light of COVID-19

COVID-19 can negatively impact critical drug development activities such as patient recruitment, patient safety and ensuring data integrity. As a result, clinical developers should review their planned regulatory filing strategies to determine if modifications are required. Many of the leading regulatory agencies, including the FDA, EMA, and MHRA, have recently issued new guidance as it relates to mitigating actions sponsors should take.

Watch this webinar to learn mitigation strategies and best practices for regulatory filings that you can begin implementing now.

To learn more, visit us at https://www.certara.com

Комментарии

Информация по комментариям в разработке

Похожие видео